Insomnia Market

Global Insomnia Market is valued around USD 4494.51 Million in 2018 and expected to reach USD 6091.87 Million by 2025 with the CAGR of 4.44% over the forecast period.

Increasing demand for sleep Aids and therapys, growing demand of OTC sleep aids and stressful life with unsatisfactory sleep, increased workloads and shift works are some factors driving the growth of the market.

Scope of the Global Insomnia-

Insomnia may be a common disorder which will make it hard to nod off, hard to remain asleep, or cause you to awaken too early and not be ready to revisit to sleep. You'll still feel tired once you awaken. Insomnia can give harmful effect not only your energy level and mood but also your health, work performance and quality of life.

How much sleep is enough varies from person to person, but most adults need seven to eight hours an evening. At some point, many adults experience short-term (acute) insomnia, which lasts for days or weeks, (for example, when you can't fall asleep the night before an exam or after receiving stressful or bad news). It's always the results of stress or a traumatic event. But some people have long-term (chronic insomnia), which is disrupted sleep that occurs at least three nights per week and lasts at least three months. Chronic insomnia disorders can have many causes. Changes within the environment, harmful sleep habits, shift work, other clinical disorders, and certain medications could lead on to a long-term pattern of unsatisfactory sleep. People with chronic insomnia may enjoy some sort of treatment to assist them revisit to healthy sleep patterns. Chronic insomnia are often co morbid, meaning it's linked to a different medical or psychiatric issue, although sometimes it's difficult to know this cause and effect relationship.

People with insomnia tend to possess difficulty falling asleep (onset), staying asleep (maintenance), and/or they awaken too early within the morning. Insomnia can include behavioral, psychological, medical components or some combination thereof for treatment.

Insomnia Market is segmented on the basis of Product Type, Therapy and region country level. On the basis of product type, the market is segmented into Prescription Sleep Aids, OTC Sleep Aids and Others. On the basis of Therapy, the market is segmented into Non-pharmacological Therapy and Pharmacological Therapy.

Insomnia Market Top Key Players-

• Merck & Co. Inc.
• Sanofi
• Pfizer Inc.
• Takeda Pharmaceutical Company Ltd
• Purdue Pharmaceuticals L.P.
• Eisai Co. Ltd.
• Meda Consumer Healthcare Inc.
• Pernix Therapeutics
• Vanda Pharmaceuticals
• ECR Pharmaceuticals
• Neurim
• Astellas
• Flynn Pharma
• SkyePharma
• Biocodex S A
• Consumer Healthcare Inc.
• Dainippon Sumitomo.
• CURRAX PHARMACEUTICAL LLC.
• MINERVA NEUROSCIENCE INC.
• Zydus Cadila

Global Insomnia Market Segmentation-

By Product Type-

• Anterior Uveitis,
• Posterior Uveitis,
• Intermediate Uveitis,
• Panuveitis

By Application Type-

• Hospital Pharmacies,
• Retail Pharmacies,
• Online Pharmacies,
• Drug Store

Global Insomnia Market Dynamics-

Increasing numbers of insomnia patients and prevalence of OTC drugs are the main factors of this market as per consumer reports survey of 1,767 U.S. adults; nearly one-third of individuals who complained of sleep problems a minimum of once per week said that they had used an over-the-counter or prescription sleep drug within the previous year. Around 40% of individuals who take sleep aids use the drugs in potentially harmful ways by, for instance, taking them frequently or longer than recommended, or combining them with other medications or alcohol. 80% people had sleeping problems once in a week. 31% people who had sleep problems once in a week used OTC or Rx drugs.

High cost of treatment like; Insomnia is costing the average U.S. worker 11.3 days, or USD 2,280 in lost productivity every year, Sleeping pills can cost from USD 17 to USD 60 a week. Some newer drugs may cost even more.

Sleeping pills are one among the most-prescribed drugs within the US. This is partly because many patients ask for them. Also, many doctors prescribe sleeping pills instead of trying other treatments first and Technological advancement, increasing numbers of hospitals, diagnostic centers, online treatments are some factors which could be the opportunity for the market.

Regional Analysis For Insomnia Market-

North America dominate the Insomnia Market

North America is dominating the market of insomnia as per US National Library of drugs , Insomnia is costing the typical U.S. worker 11.3 days, or USD 2,280 in lost productivity once a year and as a nation, the whole cost is 252.7 days and USD 63.2 billion. Europe is leading the market after North America Europe is that the market during which the entire annual cost of insomnia within the province of Quebec was estimated at USD 6.6 billion (Cdn$). the typical annual per-person costs was USD 5,010 for people with insomnia syndrome, USD 1,431 for people presenting with symptoms, and USD 421 permanently sleepers. thanks to its rising population Asia Pacific is growing marketplace for Insomnia Market and also lower hospital treatment cost compare to other regions.

On Special Requirement Insomnia Market Report is also available for the below Regions and Countries-

The regions covered in this Insomnia Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of Insomnia is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

North America

• U.S.
• Canada

Europe

• Germany
• France
• U.K.
• Italy
• Spain
• Sweden
• Netherland
• Turkey
• Switzerland
• Belgium
• Rest of Europe

Asia-Pacific

• South Korea
• Japan
• China
• India
• Australia
• Philippines
• Singapore
• Malaysia
• Thailand
• Indonesia
• Rest Of APAC

Latin America

• Mexico
• Colombia
• Brazil
• Argentina
• Peru
• Rest of South America

Middle East and Africa

• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest Of MEA

Report Analysis	Details
Historical data	2018 - 2025
Forecast Period	2018 - 2025
Market Size in 2018:	USD 4494.51 Million
Base year considered	2018
Forecast Period CAGR %:	4.44%
Market Size Expected in 2025:	USD 6091.87 Million
Tables, Charts & Figures:	175
Pages	200
Companies/Key Players	Merck & Co. Inc., Sanofi, Pfizer Inc., Takeda Pharmaceutical Company Ltd, Purdue Pharmaceuticals L.P., Eisai, Co. Ltd., Meda Consumer Healthcare Inc., Pernix Therapeutics, Vanda Pharmaceuticals, ECR Pharmaceuticals, Neurim, Astellas, Flynn Pharma, SkyePharma, Biocodex S A, Consumer Healthcare Inc., Dainippon Sumitomo., CURRAX PHARMACEUTICAL LLC., MINERVA NEUROSCIENCE INC., Zydus Cadila, and others.
Segments Covered	By Product Type, By Application
Regional Analysis	North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa

Key Benefits for Insomnia Market Reports-

• Global market report covers in depth historical and forecast analysis.
• Global market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
• Global market report helps to identify opportunities in marketplace.
• Global market report covers extensive analysis of emerging trends and competitive landscape.